Literature DB >> 25015088

Whither whole brain radiotherapy for primary CNS lymphoma?

Lisa M DeAngelis1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25015088      PMCID： PMC4096185          DOI： 10.1093/neuonc/nou122

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  15 in total

1.  Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation.

Authors:  Yuta Shibamoto; Naofumi Hayabuchi; Jun-ichi Hiratsuka; Sunao Tokumaru; Hiroki Shirato; Mitsuharu Sougawa; Natsuo Oya; Yuji Uematsu; Masahiro Hiraoka
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

2.  High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Authors:  Eckhard Thiel; Agnieszka Korfel; Peter Martus; Lothar Kanz; Frank Griesinger; Michael Rauch; Alexander Röth; Bernd Hertenstein; Theda von Toll; Thomas Hundsberger; Hans-Günther Mergenthaler; Malte Leithäuser; Tobias Birnbaum; Lars Fischer; Kristoph Jahnke; Ulrich Herrlinger; Ludwig Plasswilm; Thomas Nägele; Torsten Pietsch; Michael Bamberg; Michael Weller
Journal:  Lancet Oncol       Date:  2010-10-20       Impact factor: 41.316

3.  Cognitive functions in primary CNS lymphoma after single or combined modality regimens.

Authors:  Denise D Correa; Weiji Shi; Lauren E Abrey; Lisa M Deangelis; Antonio M Omuro; Mariel B Deutsch; Howard T Thaler
Journal:  Neuro Oncol       Date:  2011-10-19       Impact factor: 12.300

4.  Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.

Authors:  D F Nelson; K L Martz; H Bonner; J S Nelson; J Newall; H D Kerman; J W Thomson; K J Murray
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

5.  Delayed neurotoxicity in primary central nervous system lymphoma.

Authors:  Antonio M P Omuro; Leah S Ben-Porat; Katherine S Panageas; Amy K Kim; Denise D Correa; Joachim Yahalom; Lisa M Deangelis; Lauren E Abrey
Journal:  Arch Neurol       Date:  2005-10

6.  Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.

Authors:  Igor T Gavrilovic; Adília Hormigo; Joachim Yahalom; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

7.  High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

Authors:  J Y Blay; T Conroy; C Chevreau; A Thyss; N Quesnel; H Eghbali; R Bouabdallah; B Coiffier; J P Wagner; A Le Mevel; D Dramais-Marcel; E Baumelou; F Chauvin; P Biron
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

8.  A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients.

Authors:  D D Correa; J C Root; R Baser; D Moore; K K Peck; E Lis; T B Shore; H T Thaler; A Jakubowski; N Relkin
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

9.  Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

Authors:  Carole Soussain; Khê Hoang-Xuan; Luc Taillandier; Emmanuelle Fourme; Sylvain Choquet; Francis Witz; Olivier Casasnovas; Brigitte Dupriez; Bertrand Souleau; Anne-Laure Taksin; Christian Gisselbrecht; Arnaud Jaccard; Antonio Omuro; Marc Sanson; Maud Janvier; Brigitte Kolb; Jean-Marc Zini; Véronique Leblond
Journal:  J Clin Oncol       Date:  2008-04-14       Impact factor: 44.544

10.  Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy.

Authors:  Denise D Correa; Mary Rocco-Donovan; Lisa M DeAngelis; Rima Dolgoff-Kaspar; Fabio Iwamoto; Joachim Yahalom; Lauren E Abrey
Journal:  J Neurooncol       Date:  2008-11-01       Impact factor: 4.130
View more
  5 in total

1.  Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy.

Authors:  Prakash Ambady; Matthias Holdhoff; David Bonekamp; Fay Wong; Stuart A Grossman
Journal:  CNS Oncol       Date:  2015-10-28

2.  Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy.

Authors:  Yoo-Kang Kwak; Byung-Ock Choi; Kyu Hye Choi; Jong Hoon Lee; Soo Yoon Sung; Yun Hee Lee
Journal:  Oncotarget       Date:  2017-11-10

3.  Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.

Authors:  Prakash Ambady; Rongwei Fu; Joao Prola Netto; Cymon Kersch; Jenny Firkins; Nancy D Doolittle; Edward A Neuwelt
Journal:  Fluids Barriers CNS       Date:  2017-06-02

Review 4.  The Role of Radiation Therapy in the Older Patient.

Authors:  Ammoren Dohm; Roberto Diaz; Ronica H Nanda
Journal:  Curr Oncol Rep       Date:  2021-01-02       Impact factor: 5.075

5.  Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience.

Authors:  Michio Iwabuchi; Yuta Shibamoto; Chikao Sugie; Shiho Ayakawa; Hiroyuki Ogino; Fumiya Baba
Journal:  J Radiat Res       Date:  2015-12-09       Impact factor: 2.724
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.